Exchange: NYSE·Updated 07:34 PM EDT
SNN logo

SNNSmith & Nephew plc

$30.21
$0.22
(0.72%)
Today
Closed $30.21
$0.00
(0.00%)
After Hours
EarningsAug 4
Mkt Cap$12.72B
Vol1.13M
News
all
press releases
Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery
SNN launches the LYNX COBLATION Laryngeal Wand, combining precise dissection, rapid debulking and hemostasis for airway procedures.
Zacks
More News
VEEV Boosts MedTech Quality Management With Smith+Nephew Partnership
Veeva Systems expands its medtech reach as Smith+Nephew adopts Veeva Quality Cloud to modernize global quality operations and training.
Zacks
Smith & Nephew To Repurchase Up To $250 Mln Of Shares
false
Nasdaq News: Markets
SNN vs. BSX: Which Stock Is the Better Value Option?
SNN vs. BSX: Which Stock Is the Better Value Option?
Zacks
Smith & Nephew (LON:SN) Given Neutral Rating at UBS Group
UBS Group restated a 'neutral' rating and issued a GBX 1,300 price objective on shares of Smith & Nephew in a research report on Tuesday...
MarketBeat
Smith & Nephew (LON:SN) Earns "Hold" Rating from Berenberg Bank
Berenberg Bank reaffirmed a "hold" rating and set a GBX 13 price objective on shares of Smith & Nephew in a research report on Friday...
MarketBeat
Teachers Retirement System of The State of Kentucky Purchases 144,800 Shares of Smith & Nephew SNATS, Inc. $SNN
Teachers Retirement System of The State of Kentucky boosted its position in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Free Report) by 31.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 599,500 shares...
MarketBeat
Smith & Nephew SNATS, Inc. (NYSE:SNN) Receives Consensus Recommendation of "Hold" from Brokerages
Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Get Free Report) have been assigned an average rating of "Hold" from the five brokerages that are covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold rating and one has issued a strong buy rating on the c...
MarketBeat
SNN's CARTIHEAL Cartilage Implant Beats Standard Care in 5-Year Study
Smith+Nephew's CARTIHEAL implant shows superior 5-year outcomes vs. standard care, with a new CPT code set to boost adoption and expand cartilage repair reach.
Zacks
Smith & Nephew plc (LON:SN) Given Consensus Recommendation of "Hold" by Brokerages
Shares of Smith & Nephew plc (LON:SN - Get Free Report) have received a consensus rating of "Hold" from the six research firms that are presently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the c...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.